Bromotaxol

Drug Profile

Bromotaxol

Alternative Names: 2'Br-C16-HTD; alpha-bromo-hexadecanoyl paclitaxel

Latest Information Update: 30 Jul 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator The Liposome Company
  • Class Antineoplastics
  • Mechanism of Action Tubulin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 31 May 2000 The Liposome Company has been acquired by Elan Corporation
  • 14 Apr 1999 A preclinical study has been added to the pharmacodynamics section
  • 18 Nov 1998 A reference has been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top